We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
Read MoreHide Full Article
Equifax Inc. (EFX - Free Report) has an impressive Growth Score of A. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth. The company’s 2021 and 2022 earnings are expected to improve 9.2% and 15.8%, respectively, year over year.
The stock has gained 49.8% in the past year against 19.4% decline of the industry it belongs to.
Equifax serves a wide range of industries, such as financial, mortgage, consumer, employees, telecommunications, automotive, commercial, retail, government, resellers and others. This diversified client base is extremely beneficial as weakness in any sector can be balanced with strength in the others.
Equifax’s top line has shown decent growth rates in the last few years. Total revenues have witnessed a compounded annual growth rate (CAGR) of 5.6% in the last five years (2016-2020). Revenues improved 26.6% year over year in the first quarter of 2021.
We believe synergies from acquisitions, in addition to continued general consumer credit activity, product innovation, initiatives to foster enterprise growth and efficient business executions, will continue to drive Equifax’s revenues over the long run.
Debt Woes Stay
Equifax’s total debt at the end of third-quarter 2021 was 4.96 billion, up from $3.28 billion at the end of the prior quarter. The company’s cash and cash equivalent of $2.03 billion at the end of the quarter was well below this debt level, underscoring the fact that the company does not have enough cash to meet this debt burden. Further, the cash level cannot even meet the short-term debt of $500.6 million.
Avis Budget has an expected earnings growth rate of around 453.5% for the current year. CAR has a trailing four-quarter earnings surprise of 76.9%, on average.
Avis Budget’s shares have surged 478.6% in the past year. CAR has a long-term earnings growth of 18.8%. CAR sports a Zacks Rank #1.
Cross Country Healthcare has an expected earnings growth rate of around 500% for the current year. CCRN has a trailing four-quarter earnings surprise of 75%, on average.
Cross Country Healthcare’s shares have surged 168.6% in the past year. CCRN has a long-term earnings growth of 21.5%. CCRN carries a Zacks Rank #1.
CRA International has an expected earnings growth rate of around 61.2% for the current year. CRAI has a trailing four-quarter earnings surprise of 51%, on average.
CRA International’s shares have surged 77.9% in the past year. CRAI has a long-term earnings growth of 15.5%. The stock carries a Zacks Rank #2 (Buy).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
Equifax Inc. (EFX - Free Report) has an impressive Growth Score of A. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth. The company’s 2021 and 2022 earnings are expected to improve 9.2% and 15.8%, respectively, year over year.
The stock has gained 49.8% in the past year against 19.4% decline of the industry it belongs to.
Equifax, Inc. Price and Consensus
Equifax, Inc. price-consensus-chart | Equifax, Inc. Quote
What’s Behind the Rally?
Equifax serves a wide range of industries, such as financial, mortgage, consumer, employees, telecommunications, automotive, commercial, retail, government, resellers and others. This diversified client base is extremely beneficial as weakness in any sector can be balanced with strength in the others.
Equifax’s top line has shown decent growth rates in the last few years. Total revenues have witnessed a compounded annual growth rate (CAGR) of 5.6% in the last five years (2016-2020). Revenues improved 26.6% year over year in the first quarter of 2021.
We believe synergies from acquisitions, in addition to continued general consumer credit activity, product innovation, initiatives to foster enterprise growth and efficient business executions, will continue to drive Equifax’s revenues over the long run.
Debt Woes Stay
Equifax’s total debt at the end of third-quarter 2021 was 4.96 billion, up from $3.28 billion at the end of the prior quarter. The company’s cash and cash equivalent of $2.03 billion at the end of the quarter was well below this debt level, underscoring the fact that the company does not have enough cash to meet this debt burden. Further, the cash level cannot even meet the short-term debt of $500.6 million.
Zacks Rank and Stocks to Consider
Equifax currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Avis Budget (CAR - Free Report) , Cross Country Healthcare, Inc. (CCRN - Free Report) and CRA International, Inc. (CRAI - Free Report) .
Avis Budget has an expected earnings growth rate of around 453.5% for the current year. CAR has a trailing four-quarter earnings surprise of 76.9%, on average.
Avis Budget’s shares have surged 478.6% in the past year. CAR has a long-term earnings growth of 18.8%. CAR sports a Zacks Rank #1.
Cross Country Healthcare has an expected earnings growth rate of around 500% for the current year. CCRN has a trailing four-quarter earnings surprise of 75%, on average.
Cross Country Healthcare’s shares have surged 168.6% in the past year. CCRN has a long-term earnings growth of 21.5%. CCRN carries a Zacks Rank #1.
CRA International has an expected earnings growth rate of around 61.2% for the current year. CRAI has a trailing four-quarter earnings surprise of 51%, on average.
CRA International’s shares have surged 77.9% in the past year. CRAI has a long-term earnings growth of 15.5%. The stock carries a Zacks Rank #2 (Buy).